Insider Transactions in Q1 2021 at Inovio Pharmaceuticals, Inc. (INO)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 26
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,710
-7.26%
|
$37,680
$8.97 P/Share
|
|
Mar 25
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,247
-10.05%
|
$65,223
$9.06 P/Share
|
|
Mar 25
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,667
+18.78%
|
-
|
|
Mar 21
2021
|
Ann Calby Miller Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,274
+20.51%
|
-
|
|
Mar 16
2021
|
Simon X Benito Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.73%
|
$20,000
$10.41 P/Share
|
|
Mar 16
2021
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.59%
|
$6,000
$3.56 P/Share
|
|
Mar 12
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,881
-23.35%
|
$168,810
$10.06 P/Share
|
|
Mar 11
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,974
-26.43%
|
$259,740
$10.57 P/Share
|
|
Mar 11
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,737
+37.81%
|
-
|
|
Mar 11
2021
|
Jong Joseph Kim Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
74,545
-5.72%
|
$745,450
$10.57 P/Share
|
|
Mar 11
2021
|
Jong Joseph Kim Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
139,387
+9.66%
|
-
|
|
Mar 11
2021
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,667
+1.35%
|
-
|
|
Mar 11
2021
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
25,967
-22.54%
|
$259,670
$10.57 P/Share
|
|
Mar 11
2021
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,737
+34.15%
|
-
|
|
Mar 11
2021
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,410
-15.53%
|
$314,100
$10.57 P/Share
|
|
Mar 11
2021
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
59,737
+22.81%
|
-
|
|
Mar 09
2021
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
3,500
-0.41%
|
$31,500
$9.6 P/Share
|
|
Mar 08
2021
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,288
-7.34%
|
$90,304
$8.91 P/Share
|
|
Mar 08
2021
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,467
+12.25%
|
-
|
|
Mar 08
2021
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,667
+1.36%
|
-
|
|
Mar 08
2021
|
David B. Weiner Director |
SELL
Open market or private sale
|
Direct |
3,500
-0.42%
|
$31,500
$9.18 P/Share
|
|
Mar 08
2021
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,882
-11.04%
|
$55,056
$8.91 P/Share
|
|
Mar 08
2021
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,900
+24.2%
|
-
|
|
Mar 08
2021
|
Jong Joseph Kim Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
34,067
-2.84%
|
$272,536
$8.91 P/Share
|
|
Mar 08
2021
|
Jong Joseph Kim Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
63,700
+5.05%
|
-
|
|
Mar 05
2021
|
Peter Kies CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
14,574
-9.92%
|
$131,166
$9.19 P/Share
|
|
Mar 05
2021
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,566
+15.8%
|
-
|
|
Mar 05
2021
|
David B. Weiner Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,666
+1.37%
|
-
|
|
Mar 05
2021
|
Laurent Humeau Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,632
-18.5%
|
$86,688
$9.19 P/Share
|
|
Mar 05
2021
|
Laurent Humeau Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,566
+34.62%
|
-
|
|
Mar 05
2021
|
Jong Joseph Kim Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
64,230
-5.36%
|
$578,070
$9.19 P/Share
|
|
Mar 05
2021
|
Jong Joseph Kim Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
120,100
+9.11%
|
-
|
|
Feb 16
2021
|
Simon X Benito Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.73%
|
$28,000
$14.68 P/Share
|
|
Feb 16
2021
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+3.59%
|
$6,000
$3.56 P/Share
|
|
Feb 03
2021
|
Jong Joseph Kim Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
62,500
-5.48%
|
$875,000
$14.24 P/Share
|
|
Feb 03
2021
|
Jong Joseph Kim Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,500
+5.19%
|
$250,000
$4.56 P/Share
|
|
Feb 01
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,336
-23.43%
|
$425,040
$15.03 P/Share
|
|
Feb 01
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,376
+25.07%
|
$67,128
$3.62 P/Share
|
|
Feb 01
2021
|
Jong Joseph Kim Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
100,000
-8.49%
|
$1,500,000
$15.0 P/Share
|
|
Jan 28
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,713
-27.31%
|
$200,556
$12.04 P/Share
|
|
Jan 28
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,248
+47.44%
|
$165,744
$3.62 P/Share
|
|
Jan 27
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
28,336
-57.62%
|
$340,032
$12.03 P/Share
|
|
Jan 27
2021
|
Jacqueline Elizabeth Shea Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
22,376
+39.48%
|
$67,128
$3.62 P/Share
|
|
Jan 15
2021
|
Jay Shepard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,274
+50.0%
|
-
|
|
Jan 15
2021
|
Peter Kies CFO |
SELL
Open market or private sale
|
Direct |
30,000
-20.1%
|
$300,000
$10.02 P/Share
|
|
Jan 15
2021
|
Peter Kies CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+16.73%
|
$120,000
$4.56 P/Share
|
|
Jan 05
2021
|
Lota S. Zoth Director |
SELL
Open market or private sale
|
Direct |
961
-5.93%
|
$8,649
$9.48 P/Share
|
|
Jan 04
2021
|
Simon X Benito Director |
SELL
Open market or private sale
|
Direct |
2,750
-5.06%
|
$24,750
$9.0 P/Share
|
|
Jan 04
2021
|
Simon X Benito Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,750
+4.81%
|
$8,250
$3.56 P/Share
|
|
Jan 03
2021
|
Lota S. Zoth Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,090
+20.16%
|
-
|